Safety study of the EAS1 system for small lung tumors
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new system called EAS1 for people with early-stage lung cancer who are already scheduled for surgery. The goal is to see if the device is safe and works well, and it may offer a less invasive way to remove small lung tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have early-stage lung cancer (cT1a-T1c, cN0) with a tumor that is 30 mm or smaller.
- You are scheduled for or eligible for surgery to remove the lung tumor.
- Your lungs are healthy enough for surgery (tests like breathing function and oxygen levels are within certain limits).
- You are not taking blood thinners that cannot be stopped before the procedure, and you do not have other major health issues that would make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new surgical robot that uses only one small opening in the chest to remove a lung segment or lobe. It aims to see if the robot is safe and effective for patients who need this type of surgery.
This study tests a new way to treat small lung cancers during a scope procedure, followed by surgery. The treatment uses freezing and heat to destroy the tumor, and the study checks how safe and effective it is.
This trial tests a special imaging tool that helps surgeons see lung cancer tissue during surgery, so they can remove it more completely. It may help people having surgery to remove a lung tumor.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This study tests a new robot-assisted system to perform chest surgeries, such as removing lung tumors. It aims to see if the robot is safe and effective for people who need these procedures.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.